Rockwell Medical, Inc. – NASDAQ:RMTI
Rockwell Medical stock price today
$1.05
-1.09
-50.93%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 12 hours
Rockwell Medical stock price monthly change
+0.47%
month
Rockwell Medical stock price quarterly change
+0.47%
quarter
Rockwell Medical stock price yearly change
+11.46%
year
Rockwell Medical key metrics
Market Cap | 64.96M |
Enterprise value | 6.73M |
P/E | -1.08 |
EV/Sales | 0.09 |
EV/EBITDA | -0.52 |
Price/Sales | 0.32 |
Price/Book | 1.67 |
PEG ratio | -0.01 |
EPS | -0.35 |
Revenue | 86.62M |
EBITDA | -5.79M |
Income | -8.42M |
Revenue Q/Q | 15.29% |
Revenue Y/Y | 13.44% |
Profit margin | -25.65% |
Oper. margin | -23.05% |
Gross margin | 5.6% |
EBIT margin | -23.05% |
EBITDA margin | -6.69% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeRockwell Medical stock price history
Rockwell Medical stock forecast
Rockwell Medical financial statements
| Jun 2023 | 18.08M | -3.30M | -18.28% |
|---|---|---|---|
| Sep 2023 | 23.77M | -1.87M | -7.88% |
| Dec 2023 | 22.09M | -1.51M | -6.84% |
| Mar 2024 | 22.67M | -1.73M | -7.63% |
| Dec 2023 | 22.09M | -1.51M | -6.84% |
|---|---|---|---|
| Mar 2024 | 22.67M | -1.73M | -7.63% |
| Oct 2025 | 26.6M | 293.27K | 1.1% |
| Dec 2025 | 27.6M | 879.81K | 3.19% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 38037000 | 28.50M | 74.95% |
|---|---|---|---|
| Sep 2023 | 52606000 | 31.08M | 59.1% |
| Dec 2023 | 52173000 | 30.88M | 59.19% |
| Mar 2024 | 50723000 | 30.08M | 59.3% |
| Jun 2023 | -1.74M | -64K | -130K |
|---|---|---|---|
| Sep 2023 | -3.75M | -10.29M | 12.84M |
| Dec 2023 | -43K | 2.00M | -742K |
| Mar 2024 | -2.38M | -139K | 178K |
Rockwell Medical alternative data
| Aug 2023 | 253 |
|---|---|
| Sep 2023 | 253 |
| Oct 2023 | 253 |
| Nov 2023 | 253 |
| Dec 2023 | 253 |
| Jan 2024 | 253 |
| Feb 2024 | 253 |
| Mar 2024 | 237 |
| Apr 2024 | 237 |
| May 2024 | 237 |
| Jun 2024 | 237 |
| Jul 2024 | 237 |
Rockwell Medical other data
11.35%
-15.93%
of RMTI is owned by hedge funds
1.12M
-1.75M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Oct 2024 | 0 | 3164 |
| Nov 2024 | 0 | 29991 |
| Patent |
|---|
Application Filling date: 4 Aug 2020 Issue date: 19 Nov 2020 |
| Quarter | Transcript |
|---|---|
| Q1 2024 14 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 21 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 14 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 14 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Dr. Russell H. Ellison M.Sc., M.D., MSc. (1948) Pres, Chief Executive Officer & Director | $705,920 |
| Dr. Raymond Dennis Pratt (1951) Chief Devel. Officer | $581,110 |
Mr. Russell L. Skibsted M.B.A. (1959) Executive Vice President, Chief Financial Officer & Chief Bus. Officer | $448,940 |
-
What's the price of Rockwell Medical stock today?
One share of Rockwell Medical stock can currently be purchased for approximately $1.05.
-
When is Rockwell Medical's next earnings date?
Unfortunately, Rockwell Medical's (RMTI) next earnings date is currently unknown.
-
Does Rockwell Medical pay dividends?
No, Rockwell Medical does not pay dividends.
-
How much money does Rockwell Medical make?
Rockwell Medical has a market capitalization of 64.96M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 14.84% to 83.61M US dollars.
-
What is Rockwell Medical's stock symbol?
Rockwell Medical, Inc. is traded on the NASDAQ under the ticker symbol "RMTI".
-
What is Rockwell Medical's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Rockwell Medical?
Shares of Rockwell Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Rockwell Medical's key executives?
Rockwell Medical's management team includes the following people:
- Dr. Russell H. Ellison M.Sc., M.D., MSc. Pres, Chief Executive Officer & Director(age: 77, pay: $705,920)
- Dr. Raymond Dennis Pratt Chief Devel. Officer(age: 74, pay: $581,110)
- Mr. Russell L. Skibsted M.B.A. Executive Vice President, Chief Financial Officer & Chief Bus. Officer(age: 66, pay: $448,940)
-
How many employees does Rockwell Medical have?
As Jul 2024, Rockwell Medical employs 237 workers.
-
When Rockwell Medical went public?
Rockwell Medical, Inc. is publicly traded company for more then 27 years since IPO on 27 Jan 1998.
-
What is Rockwell Medical's official website?
The official website for Rockwell Medical is rockwellmed.com.
-
Where are Rockwell Medical's headquarters?
Rockwell Medical is headquartered at 30142 South Wixom road, Wixom, MI.
-
How can i contact Rockwell Medical?
Rockwell Medical's mailing address is 30142 South Wixom road, Wixom, MI and company can be reached via phone at +248 9609009.
Rockwell Medical company profile:
Rockwell Medical, Inc.
rockwellmed.comExchange:
NASDAQ
Full time employees:
237
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
30142 South Wixom road
Wixom, MI 48393
Wixom, MI 48393
CIK: 0001041024
ISIN: US7743743004
CUSIP: 774374300
